Audentes Therapeutics (BOLD) Tops Q4 EPS by 8c
Tweet
Share
E-mail
Get Alerts BOLD Hot Sheet
Join SI Premium – FREE
Audentes Therapeutics (NASDAQ: BOLD) reported Q4 EPS of ($0.84), $0.08 better than the analyst estimate of ($0.92).
For earnings history and earnings-related data on Audentes Therapeutics (BOLD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wex, Inc. (WEX) Tops Q2 EPS by 29c; raises guidance
- Wyndham Hotels & Resorts, Inc. (WH) Tops Q2 EPS by 8c ; Offers Guidance
- Live Oak Bancshares, Inc. (LOB) Tops Q2 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
